Sg Americas Securities, LLC Cytom X Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$1.41 - $2.74 $36,820 - $71,552	26,114 New	26,114 $57,000
Q2 2022 Jul 29, 2022	SELL	$1.53 - $2.89 $22,230 - $41,991	-14,530 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$2.67 - $4.68 $11,537 - $20,222	4,321 Added 42.33%	14,530 $39,000
Q4 2021 Feb 07, 2022	SELL	$3.87 - $7.39 $79,865 - $152,507	-20,637 Reduced 66.9%	10,209 $44,000
Q3 2021 Nov 01, 2021	BUY	$4.32 - $6.43 $83,255 - $123,918	19,272 Added 166.51%	30,846 $157,000
Q2 2021 Aug 12, 2021	SELL	$6.33 - $9.91 $12,039 - $18,848	-1,902 Reduced 14.11%	11,574 $73,000
Q1 2021 May 13, 2021	BUY	$6.6 - $9.0 $88,941 - $121,284	13,476 New	13,476 $104,000
Q4 2020 Feb 04, 2021	SELL	$6.47 - $7.9 $141,026 - $172,196	-21,797 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$6.55 - $8.83 $63,528 - $85,642	9,699 Added 80.17%	21,797 $145,000
Q2 2020 Jul 20, 2020	SELL	$7.4 - $14.64 $38,901 - $76,962	-5,257 Reduced 30.29%	12,098 $101,000
Q1 2020 Apr 30, 2020	BUY	$3.61 - $8.6 $62,651 - $149,253	17,355 New	17,355 $133,000
Q3 2018 Nov 06, 2018	SELL	$18.04 - $26.41 $93,808 - $137,332	-5,200 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$21.38 - $29.68 $111,176 - $154,336	5,200 New	5,200 $119,000

50.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.